Kv1.3 ion channel mAbs (Tetragenetics)

N/A

Report date: 2025/03/20 16:07:42

Base Information

Drug NameKv1.3 ion channel mAbs (Tetragenetics)
Drug Alias NameKv1.3 ion channel mAbs (AbCellera)Kv1.3 ion channel targeting antibodies (Tetragenetics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.3 modulators
TargetsVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetragenetics
China Registration ClassN/A

Develop Information

Active CompaniesAbCellera Biologics Inc
Inactive CompaniesTetragenetics
Active IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A